In a clinical trial, efficacy and safety of melatonin and oral midazolam in induction of sedation of 80 children 1-10years old referred to electroencephalography unit, will be evaluated.
The patients will randomly be assigned to receive either 0.3 mg/kg/dose of melatonin or 0.75mg/kg oral midazolam until Ramsay score of four is attained and recording of EEG is done successfully.
Vital signs, cyanosis, respiratory state, apnea and any side effect will be evaluated in children for two hours after drug use. Efficacy of drugs in sedation induction, time to induction of sedation, total stay time in EEG unit, serious adverse events (hypotension, hypoxia and cyanosis, severe vomiting, irritability, apnea, laryngospasm, and bradycardia), and caregiver’s satisfaction are also compared between groups.